4//SEC Filing
Garrison Michael David 4
Accession 0001944816-26-000002
CIK 0000010795other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 3:43 PM ET
Size
11.0 KB
Accession
0001944816-26-000002
Insider Transaction Report
Form 4
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm
Transactions
- Exercise/Conversion
Common Stock
2026-01-15$167.91/sh+3,054$512,797→ 16,159 total - Disposition to Issuer
Common Stock
2026-01-15$209.00/sh−2,454$512,886→ 13,705 total - Sale
Common Stock
2026-01-15$209.00/sh−600$125,400→ 13,105 total - Sale
Common Stock
2026-01-15$206.54/sh−1,010$208,605→ 12,095 total - Exercise/Conversion
Stock Appreciation Rights
[F1]2026-01-15−3,054→ 0 totalExercise: $167.91From: 2017-11-26Exp: 2026-11-26→ Common Stock (3,054 underlying)
Footnotes (1)
- [F1]The stock appreciation rights vested in four annual installments beginning one year from the grant date.
Signature
Donna Kalazdy, by power of attorney from Michael David Garrison|2026-01-16
Documents
Issuer
BECTON DICKINSON & CO
CIK 0000010795
Entity typeother
Related Parties
1- filerCIK 0001944816
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 3:43 PM ET
- Size
- 11.0 KB